aluates Reports

$ 0.0

Automative

Global Digital Therapeutics for Psychiatric Illnesses Market Research Report 2025

Published Date: April 2025

Report Code: QYRE-Auto-10Y13073

Global Digital Therapeutics for Psychiatric Illnesses Market Research Report 2023

BUY CHAPTERS

Global Digital Therapeutics for Psychiatric Illnesses Market Research Report 2025

Code: QYRE-Auto-10Y13073

Report

April 2025

Pages:73

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Pear Therapeutics

Akili Interactive

Big Health

Click Therapeutics

Orexo

Limbix

Cognoa

Freespira

Shandong Xindao Artificial Intelligence Technology Co., Ltd.

Digital Therapeutics for Psychiatric Illnesses Market

The global market for Digital Therapeutics for Psychiatric Illnesses was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Digital Therapeutics for Psychiatric Illnesses are software program-driven, evidence-based interventions for the treatment, management or prevention of psychiatric illnesses.

North American market for Digital Therapeutics for Psychiatric Illnesses is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Digital Therapeutics for Psychiatric Illnesses is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Digital Therapeutics for Psychiatric Illnesses in Insomnia is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Digital Therapeutics for Psychiatric Illnesses include Pear Therapeutics, Akili Interactive, Big Health, Click Therapeutics, Orexo, Limbix, Cognoa, Freespira, Shandong Xindao Artificial Intelligence Technology Co., Ltd., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Digital Therapeutics for Psychiatric Illnesses, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Digital Therapeutics for Psychiatric Illnesses.

The Digital Therapeutics for Psychiatric Illnesses market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Digital Therapeutics for Psychiatric Illnesses market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Digital Therapeutics for Psychiatric Illnesses companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Digital Therapeutics for Psychiatric Illnesses Market Report

Report Metric	Details
Report Name	Digital Therapeutics for Psychiatric Illnesses Market
Segment by Type	Prevention Management Treatment
Segment by Application	Insomnia Depression Autistic Anxiety Disorder Schizophrenia Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pear Therapeutics, Akili Interactive, Big Health, Click Therapeutics, Orexo, Limbix, Cognoa, Freespira, Shandong Xindao Artificial Intelligence Technology Co., Ltd.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Digital Therapeutics for Psychiatric Illnesses company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Digital Therapeutics for Psychiatric Illnesses Market report?

Ans: The main players in the Digital Therapeutics for Psychiatric Illnesses Market are Pear Therapeutics, Akili Interactive, Big Health, Click Therapeutics, Orexo, Limbix, Cognoa, Freespira, Shandong Xindao Artificial Intelligence Technology Co., Ltd.

What are the Application segmentation covered in the Digital Therapeutics for Psychiatric Illnesses Market report?

Ans: The Applications covered in the Digital Therapeutics for Psychiatric Illnesses Market report are Insomnia, Depression, Autistic, Anxiety Disorder, Schizophrenia, Other

What are the Type segmentation covered in the Digital Therapeutics for Psychiatric Illnesses Market report?

Ans: The Types covered in the Digital Therapeutics for Psychiatric Illnesses Market report are Prevention, Management, Treatment

Recommended Reports

Digital Therapeutics

Psychiatric Disorders

Mental Health Treatment

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Digital Therapeutics for Psychiatric Illnesses Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Prevention

1.2.3 Management

1.2.4 Treatment

1.3 Market by Application

1.3.1 Global Digital Therapeutics for Psychiatric Illnesses Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Insomnia

1.3.3 Depression

1.3.4 Autistic

1.3.5 Anxiety Disorder

1.3.6 Schizophrenia

1.3.7 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Digital Therapeutics for Psychiatric Illnesses Market Perspective (2020-2031)

2.2 Global Digital Therapeutics for Psychiatric Illnesses Growth Trends by Region

2.2.1 Global Digital Therapeutics for Psychiatric Illnesses Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Digital Therapeutics for Psychiatric Illnesses Historic Market Size by Region (2020-2025)

2.2.3 Digital Therapeutics for Psychiatric Illnesses Forecasted Market Size by Region (2026-2031)

2.3 Digital Therapeutics for Psychiatric Illnesses Market Dynamics

2.3.1 Digital Therapeutics for Psychiatric Illnesses Industry Trends

2.3.2 Digital Therapeutics for Psychiatric Illnesses Market Drivers

2.3.3 Digital Therapeutics for Psychiatric Illnesses Market Challenges

2.3.4 Digital Therapeutics for Psychiatric Illnesses Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Digital Therapeutics for Psychiatric Illnesses Players by Revenue

3.1.1 Global Top Digital Therapeutics for Psychiatric Illnesses Players by Revenue (2020-2025)

3.1.2 Global Digital Therapeutics for Psychiatric Illnesses Revenue Market Share by Players (2020-2025)

3.2 Global Digital Therapeutics for Psychiatric Illnesses Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Digital Therapeutics for Psychiatric Illnesses Revenue

3.4 Global Digital Therapeutics for Psychiatric Illnesses Market Concentration Ratio

3.4.1 Global Digital Therapeutics for Psychiatric Illnesses Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Digital Therapeutics for Psychiatric Illnesses Revenue in 2024

3.5 Global Key Players of Digital Therapeutics for Psychiatric Illnesses Head office and Area Served

3.6 Global Key Players of Digital Therapeutics for Psychiatric Illnesses, Product and Application

3.7 Global Key Players of Digital Therapeutics for Psychiatric Illnesses, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Digital Therapeutics for Psychiatric Illnesses Breakdown Data by Type

4.1 Global Digital Therapeutics for Psychiatric Illnesses Historic Market Size by Type (2020-2025)

4.2 Global Digital Therapeutics for Psychiatric Illnesses Forecasted Market Size by Type (2026-2031)

5 Digital Therapeutics for Psychiatric Illnesses Breakdown Data by Application

5.1 Global Digital Therapeutics for Psychiatric Illnesses Historic Market Size by Application (2020-2025)

5.2 Global Digital Therapeutics for Psychiatric Illnesses Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Digital Therapeutics for Psychiatric Illnesses Market Size (2020-2031)

6.2 North America Digital Therapeutics for Psychiatric Illnesses Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Digital Therapeutics for Psychiatric Illnesses Market Size by Country (2020-2025)

6.4 North America Digital Therapeutics for Psychiatric Illnesses Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Digital Therapeutics for Psychiatric Illnesses Market Size (2020-2031)

7.2 Europe Digital Therapeutics for Psychiatric Illnesses Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Digital Therapeutics for Psychiatric Illnesses Market Size by Country (2020-2025)

7.4 Europe Digital Therapeutics for Psychiatric Illnesses Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Digital Therapeutics for Psychiatric Illnesses Market Size (2020-2031)

8.2 Asia-Pacific Digital Therapeutics for Psychiatric Illnesses Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Digital Therapeutics for Psychiatric Illnesses Market Size by Region (2020-2025)

8.4 Asia-Pacific Digital Therapeutics for Psychiatric Illnesses Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Digital Therapeutics for Psychiatric Illnesses Market Size (2020-2031)

9.2 Latin America Digital Therapeutics for Psychiatric Illnesses Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Digital Therapeutics for Psychiatric Illnesses Market Size by Country (2020-2025)

9.4 Latin America Digital Therapeutics for Psychiatric Illnesses Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Digital Therapeutics for Psychiatric Illnesses Market Size (2020-2031)

10.2 Middle East & Africa Digital Therapeutics for Psychiatric Illnesses Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Digital Therapeutics for Psychiatric Illnesses Market Size by Country (2020-2025)

10.4 Middle East & Africa Digital Therapeutics for Psychiatric Illnesses Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Pear Therapeutics

11.1.1 Pear Therapeutics Company Details

11.1.2 Pear Therapeutics Business Overview

11.1.3 Pear Therapeutics Digital Therapeutics for Psychiatric Illnesses Introduction

11.1.4 Pear Therapeutics Revenue in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025)

11.1.5 Pear Therapeutics Recent Development

11.2 Akili Interactive

11.2.1 Akili Interactive Company Details

11.2.2 Akili Interactive Business Overview

11.2.3 Akili Interactive Digital Therapeutics for Psychiatric Illnesses Introduction

11.2.4 Akili Interactive Revenue in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025)

11.2.5 Akili Interactive Recent Development

11.3 Big Health

11.3.1 Big Health Company Details

11.3.2 Big Health Business Overview

11.3.3 Big Health Digital Therapeutics for Psychiatric Illnesses Introduction

11.3.4 Big Health Revenue in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025)

11.3.5 Big Health Recent Development

11.4 Click Therapeutics

11.4.1 Click Therapeutics Company Details

11.4.2 Click Therapeutics Business Overview

11.4.3 Click Therapeutics Digital Therapeutics for Psychiatric Illnesses Introduction

11.4.4 Click Therapeutics Revenue in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025)

11.4.5 Click Therapeutics Recent Development

11.5 Orexo

11.5.1 Orexo Company Details

11.5.2 Orexo Business Overview

11.5.3 Orexo Digital Therapeutics for Psychiatric Illnesses Introduction

11.5.4 Orexo Revenue in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025)

11.5.5 Orexo Recent Development

11.6 Limbix

11.6.1 Limbix Company Details

11.6.2 Limbix Business Overview

11.6.3 Limbix Digital Therapeutics for Psychiatric Illnesses Introduction

11.6.4 Limbix Revenue in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025)

11.6.5 Limbix Recent Development

11.7 Cognoa

11.7.1 Cognoa Company Details

11.7.2 Cognoa Business Overview

11.7.3 Cognoa Digital Therapeutics for Psychiatric Illnesses Introduction

11.7.4 Cognoa Revenue in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025)

11.7.5 Cognoa Recent Development

11.8 Freespira

11.8.1 Freespira Company Details

11.8.2 Freespira Business Overview

11.8.3 Freespira Digital Therapeutics for Psychiatric Illnesses Introduction

11.8.4 Freespira Revenue in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025)

11.8.5 Freespira Recent Development

11.9 Shandong Xindao Artificial Intelligence Technology Co., Ltd.

11.9.1 Shandong Xindao Artificial Intelligence Technology Co., Ltd. Company Details

11.9.2 Shandong Xindao Artificial Intelligence Technology Co., Ltd. Business Overview

11.9.3 Shandong Xindao Artificial Intelligence Technology Co., Ltd. Digital Therapeutics for Psychiatric Illnesses Introduction

11.9.4 Shandong Xindao Artificial Intelligence Technology Co., Ltd. Revenue in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025)

11.9.5 Shandong Xindao Artificial Intelligence Technology Co., Ltd. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Pear Therapeutics

Akili Interactive

Big Health

Click Therapeutics

Orexo

Limbix

Cognoa

Freespira

Shandong Xindao Artificial Intelligence Technology Co., Ltd.

List of Tables

Table 1. Global Digital Therapeutics for Psychiatric Illnesses Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Prevention

Table 3. Key Players of Management

Table 4. Key Players of Treatment

Table 5. Global Digital Therapeutics for Psychiatric Illnesses Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Digital Therapeutics for Psychiatric Illnesses Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Digital Therapeutics for Psychiatric Illnesses Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Digital Therapeutics for Psychiatric Illnesses Market Share by Region (2020-2025)

Table 9. Global Digital Therapeutics for Psychiatric Illnesses Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Digital Therapeutics for Psychiatric Illnesses Market Share by Region (2026-2031)

Table 11. Digital Therapeutics for Psychiatric Illnesses Market Trends

Table 12. Digital Therapeutics for Psychiatric Illnesses Market Drivers

Table 13. Digital Therapeutics for Psychiatric Illnesses Market Challenges

Table 14. Digital Therapeutics for Psychiatric Illnesses Market Restraints

Table 15. Global Digital Therapeutics for Psychiatric Illnesses Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Digital Therapeutics for Psychiatric Illnesses Market Share by Players (2020-2025)

Table 17. Global Top Digital Therapeutics for Psychiatric Illnesses Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Digital Therapeutics for Psychiatric Illnesses as of 2024)

Table 18. Ranking of Global Top Digital Therapeutics for Psychiatric Illnesses Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Digital Therapeutics for Psychiatric Illnesses Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Digital Therapeutics for Psychiatric Illnesses, Headquarters and Area Served

Table 21. Global Key Players of Digital Therapeutics for Psychiatric Illnesses, Product and Application

Table 22. Global Key Players of Digital Therapeutics for Psychiatric Illnesses, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Digital Therapeutics for Psychiatric Illnesses Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Digital Therapeutics for Psychiatric Illnesses Revenue Market Share by Type (2020-2025)

Table 26. Global Digital Therapeutics for Psychiatric Illnesses Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Digital Therapeutics for Psychiatric Illnesses Revenue Market Share by Type (2026-2031)

Table 28. Global Digital Therapeutics for Psychiatric Illnesses Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Digital Therapeutics for Psychiatric Illnesses Revenue Market Share by Application (2020-2025)

Table 30. Global Digital Therapeutics for Psychiatric Illnesses Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Digital Therapeutics for Psychiatric Illnesses Revenue Market Share by Application (2026-2031)

Table 32. North America Digital Therapeutics for Psychiatric Illnesses Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Digital Therapeutics for Psychiatric Illnesses Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Digital Therapeutics for Psychiatric Illnesses Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Digital Therapeutics for Psychiatric Illnesses Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Digital Therapeutics for Psychiatric Illnesses Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Digital Therapeutics for Psychiatric Illnesses Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Digital Therapeutics for Psychiatric Illnesses Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Digital Therapeutics for Psychiatric Illnesses Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Digital Therapeutics for Psychiatric Illnesses Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Digital Therapeutics for Psychiatric Illnesses Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Digital Therapeutics for Psychiatric Illnesses Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Digital Therapeutics for Psychiatric Illnesses Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Digital Therapeutics for Psychiatric Illnesses Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Digital Therapeutics for Psychiatric Illnesses Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Digital Therapeutics for Psychiatric Illnesses Market Size by Country (2026-2031) & (US$ Million)

Table 47. Pear Therapeutics Company Details

Table 48. Pear Therapeutics Business Overview

Table 49. Pear Therapeutics Digital Therapeutics for Psychiatric Illnesses Product

Table 50. Pear Therapeutics Revenue in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025) & (US$ Million)

Table 51. Pear Therapeutics Recent Development

Table 52. Akili Interactive Company Details

Table 53. Akili Interactive Business Overview

Table 54. Akili Interactive Digital Therapeutics for Psychiatric Illnesses Product

Table 55. Akili Interactive Revenue in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025) & (US$ Million)

Table 56. Akili Interactive Recent Development

Table 57. Big Health Company Details

Table 58. Big Health Business Overview

Table 59. Big Health Digital Therapeutics for Psychiatric Illnesses Product

Table 60. Big Health Revenue in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025) & (US$ Million)

Table 61. Big Health Recent Development

Table 62. Click Therapeutics Company Details

Table 63. Click Therapeutics Business Overview

Table 64. Click Therapeutics Digital Therapeutics for Psychiatric Illnesses Product

Table 65. Click Therapeutics Revenue in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025) & (US$ Million)

Table 66. Click Therapeutics Recent Development

Table 67. Orexo Company Details

Table 68. Orexo Business Overview

Table 69. Orexo Digital Therapeutics for Psychiatric Illnesses Product

Table 70. Orexo Revenue in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025) & (US$ Million)

Table 71. Orexo Recent Development

Table 72. Limbix Company Details

Table 73. Limbix Business Overview

Table 74. Limbix Digital Therapeutics for Psychiatric Illnesses Product

Table 75. Limbix Revenue in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025) & (US$ Million)

Table 76. Limbix Recent Development

Table 77. Cognoa Company Details

Table 78. Cognoa Business Overview

Table 79. Cognoa Digital Therapeutics for Psychiatric Illnesses Product

Table 80. Cognoa Revenue in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025) & (US$ Million)

Table 81. Cognoa Recent Development

Table 82. Freespira Company Details

Table 83. Freespira Business Overview

Table 84. Freespira Digital Therapeutics for Psychiatric Illnesses Product

Table 85. Freespira Revenue in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025) & (US$ Million)

Table 86. Freespira Recent Development

Table 87. Shandong Xindao Artificial Intelligence Technology Co., Ltd. Company Details

Table 88. Shandong Xindao Artificial Intelligence Technology Co., Ltd. Business Overview

Table 89. Shandong Xindao Artificial Intelligence Technology Co., Ltd. Digital Therapeutics for Psychiatric Illnesses Product

Table 90. Shandong Xindao Artificial Intelligence Technology Co., Ltd. Revenue in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025) & (US$ Million)

Table 91. Shandong Xindao Artificial Intelligence Technology Co., Ltd. Recent Development

Table 92. Research Programs/Design for This Report

Table 93. Key Data Information from Secondary Sources

Table 94. Key Data Information from Primary Sources

Table 95. Authors List of This Report

List of Figures

Figure 1. Digital Therapeutics for Psychiatric Illnesses Picture

Figure 2. Global Digital Therapeutics for Psychiatric Illnesses Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Digital Therapeutics for Psychiatric Illnesses Market Share by Type: 2024 VS 2031

Figure 4. Prevention Features

Figure 5. Management Features

Figure 6. Treatment Features

Figure 7. Global Digital Therapeutics for Psychiatric Illnesses Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Digital Therapeutics for Psychiatric Illnesses Market Share by Application: 2024 VS 2031

Figure 9. Insomnia Case Studies

Figure 10. Depression Case Studies

Figure 11. Autistic Case Studies

Figure 12. Anxiety Disorder Case Studies

Figure 13. Schizophrenia Case Studies

Figure 14. Other Case Studies

Figure 15. Digital Therapeutics for Psychiatric Illnesses Report Years Considered

Figure 16. Global Digital Therapeutics for Psychiatric Illnesses Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 17. Global Digital Therapeutics for Psychiatric Illnesses Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 18. Global Digital Therapeutics for Psychiatric Illnesses Market Share by Region: 2024 VS 2031

Figure 19. Global Digital Therapeutics for Psychiatric Illnesses Market Share by Players in 2024

Figure 20. Global Top Digital Therapeutics for Psychiatric Illnesses Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Digital Therapeutics for Psychiatric Illnesses as of 2024)

Figure 21. The Top 10 and 5 Players Market Share by Digital Therapeutics for Psychiatric Illnesses Revenue in 2024

Figure 22. North America Digital Therapeutics for Psychiatric Illnesses Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. North America Digital Therapeutics for Psychiatric Illnesses Market Share by Country (2020-2031)

Figure 24. United States Digital Therapeutics for Psychiatric Illnesses Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Canada Digital Therapeutics for Psychiatric Illnesses Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Digital Therapeutics for Psychiatric Illnesses Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Europe Digital Therapeutics for Psychiatric Illnesses Market Share by Country (2020-2031)

Figure 28. Germany Digital Therapeutics for Psychiatric Illnesses Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. France Digital Therapeutics for Psychiatric Illnesses Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. U.K. Digital Therapeutics for Psychiatric Illnesses Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Italy Digital Therapeutics for Psychiatric Illnesses Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Russia Digital Therapeutics for Psychiatric Illnesses Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Nordic Countries Digital Therapeutics for Psychiatric Illnesses Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Digital Therapeutics for Psychiatric Illnesses Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Asia-Pacific Digital Therapeutics for Psychiatric Illnesses Market Share by Region (2020-2031)

Figure 36. China Digital Therapeutics for Psychiatric Illnesses Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Japan Digital Therapeutics for Psychiatric Illnesses Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. South Korea Digital Therapeutics for Psychiatric Illnesses Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Southeast Asia Digital Therapeutics for Psychiatric Illnesses Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. India Digital Therapeutics for Psychiatric Illnesses Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Australia Digital Therapeutics for Psychiatric Illnesses Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Digital Therapeutics for Psychiatric Illnesses Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Latin America Digital Therapeutics for Psychiatric Illnesses Market Share by Country (2020-2031)

Figure 44. Mexico Digital Therapeutics for Psychiatric Illnesses Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Brazil Digital Therapeutics for Psychiatric Illnesses Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Digital Therapeutics for Psychiatric Illnesses Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Middle East & Africa Digital Therapeutics for Psychiatric Illnesses Market Share by Country (2020-2031)

Figure 48. Turkey Digital Therapeutics for Psychiatric Illnesses Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Saudi Arabia Digital Therapeutics for Psychiatric Illnesses Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. UAE Digital Therapeutics for Psychiatric Illnesses Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Pear Therapeutics Revenue Growth Rate in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025)

Figure 52. Akili Interactive Revenue Growth Rate in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025)

Figure 53. Big Health Revenue Growth Rate in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025)

Figure 54. Click Therapeutics Revenue Growth Rate in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025)

Figure 55. Orexo Revenue Growth Rate in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025)

Figure 56. Limbix Revenue Growth Rate in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025)

Figure 57. Cognoa Revenue Growth Rate in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025)

Figure 58. Freespira Revenue Growth Rate in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025)

Figure 59. Shandong Xindao Artificial Intelligence Technology Co., Ltd. Revenue Growth Rate in Digital Therapeutics for Psychiatric Illnesses Business (2020-2025)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350